According to a new report by Univdatos, the global graves disease market is expected to reach around USD 965 Million in 2032 by growing at a CAGR of 5%. Among all autoimmune diseases, Graves’ disease which develops in the thyroid gland has acquired the status of a global clinical problem. This is a disease that is characterized by an overactivity of the thyroid gland which may cause...